Moreover, upregulation of Nrf2 activity may offer therapeutic benefits in conditions such as diabetic cardiomyopathy and mitochondrial dysfunction, and in mitigating age-related changes in the heart [117]. This evidence concerns the gene NFE2L2 and diabetic cardiomyopathy.